Which race would you rather run?

Two ways to cover a stent. Two very different races against thrombosis.

Woven Dacron and ePTFE do the same job: seal the vessel, hold the flow. But the body heals them by different routes, and that changes when each one is most likely to clot.

Woven fabric (Dacron, PET). The wall is a porous textile. Tissue can grow straight through it. Capillaries sprout from the vessel wall, cross the weave, and carry endothelium toward the surface from the outside in. In porous fabric, coverage can come faster. The catch is the starting surface. A bare textile is rough, protein hungry, and permeable to blood. Early on it is thrombogenic, which is why classic Dacron was preclotted. So fabric runs an early race: heal through the pores before a clot forms on the raw surface.

ePTFE. Clinical ePTFE is a tight node and fibril sheet. Tissue does not travel through it easily, so endothelium mostly creeps in from the edges, from the cut vessel and the device margins, a millimeter or so at a time. The middle can stay bare for a long time. Open up the porosity and ePTFE heals through the wall too, so porosity, not the polymer, is the real variable. The upside is the starting surface. ePTFE is hydrophobic and impervious, so early clot risk tends to be lower. Not inert, just quieter. That moves the danger to the other end. The question is not the first week. It is whether endothelium arrives before the bare surface keeps driving late thrombosis. ePTFE runs a late race.

Line them up. Endothelial growth: through the wall on fabric, from the edges on ePTFE. Early thrombus: higher on bare fabric, lower on ePTFE. Both clot until they heal. Late thrombus: on ePTFE it lingers until the surface covers. On fabric it tends to follow inflammation and intimal hyperplasia. Late failure is never one thing.

One honest footnote. In humans, neither route reliably finishes the job. Edge ingrowth stalls after a centimeter or two, and through the wall healing is largely blocked by the capsule that forms around the device. That unhealed middle is why late thrombogenicity is still the hard problem in covered devices.

So it is not fabric versus ePTFE. It is early risk versus late risk, and how fast tissue can win its race.

Which race would you rather run?

#MedicalDevices #CoveredStents #ePTFE #Dacron #VascularSurgery #Biomaterials #Endovascular #StentThrombosis #MedTech